English
Stay tuned!

How does the BD Totalys™ solution help improve cervical cancer screening?

Watch the testimonial video
QUALITY OF CYTOLOGY
INTERPRETATION WITH BD SUREPATH™
EXTENDED HPV GENOTYPING WITH
BD ONCLARITY™
WORKFLOW EFFICIENCY
THROUGH AUTOMATION
Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
        01
        Challenges in cervical cancer screening
        • Complete traceability, automation and quick turnaround time
        • Fewer unsatisfactory screenings with increasing sample volumes
        • Incorporating HPV testing and genotyping together with cytology results
        • Lower costs through increased productivity
        • Staff satisfaction and ease of use
        INSTITUTION
        INSTITUT DE PATHOLOGIE
        Location
        PARIS, France
        TESTIMONIAL BY
        DR. CAMILO ADEM
        02
        Why did we choose BD’s solution?

        The Institut de Pathologie de Paris had several problems with their earlier method for cervical screening

        • No automation for cytology
        • No HPV genotyping
        • No traceability
        • Too many HPV false negatives
        • Not suitable for ISO 15189 standardisation
        03
        How did the BD solution improve our work ?
        BD Totalys™ SlidePrep & BD Totalys™ MultiProcessor
        Improved quality of cytology with BD SurePath™ slides
        100% of collected sample sent to lab for cytology using the BD SurePath™ vial
        Increased detection rate of CIN2+
        Lower ASCUS/SIL ratios
        Drop in the rate of unsatisfactory slides to 0.3%
        Automation of unique cell-enrichment and slide staining process
        BD FocalPoint™ GS
        Efficient screening by focusing on relevant fields of view
        Confidence in interpretation of slides
        Remote screening options with BD FocalPoint™ Guided Screener review stations
        BD Viper™ LT
        Fewer false negative HPV results
        Internal sample cellularity control by beta-globin
        DNA based test (E6/E7 target)
        Extended HPV genotyping for patient risk stratification

        Overall benefits of the BD solution

        • Robust, flexible and efficient solution that includes both HPV screening and cytology by the same provider
        • Partnership with BD delivers complete and personalised care management
        • Extended genotyping enables better understanding of the causative agent of disease
        • Significant decrease in hands-on time and a 41% increase in productivity
        • Improved overall quality interpretation, workflow processes and turnaround time
        04
        Watch the testimonial video
        Before the BD solution, cytology was the “poor sibling’’. Today everybody wants to screen smears. The BD solution has turned cytology into something sexy.
        Dr Camilo ADEM, Pathologist, Institut de Pathologie de Paris
        Dr Camilo ADEM
        The BD FocalPoint™ provides great safety for my smear tests and a significant saving in time.
        Dr Anne BARRES, Pathologist, Institut de Pathologie de Paris
        Dr Anne BARRES
        Testimonial
        Video Player is loading.
        Current Time 0:00
        Duration 0:00
        Loaded: 0%
        Stream Type LIVE
        Remaining Time 0:00
         
        1x
          • Chapters
          • descriptions off, selected
          • captions off, selected

              Let’s get in touch!

              All infos are mandatory

              Share these stories with your friends and colleagues!